Published in Lab Business Week, September 23rd, 2007
"Using the current ZFN architecture, however, cleavage-competent homodimers may also form that can limit safety or efficacy...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-09-23)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.